Table 4.
Participant metadata pre- and post-measurement.
| Placebo baseline (N = 20) | Placebo exam stress (N = 20) | p | Probiotic baseline (N = 20) | Probiotic exam stress (N = 20) | p | |
|---|---|---|---|---|---|---|
| Compliance | – | 102.5 | – | – | 94.75 | ns |
| Days on treatment | – | 52.55 | – | – | 53.2 | ns |
| BMI | 24.14 (0.65) | 24.26 (0.72) | ns | 24.23 (0.77) | 24.1 (0.71) | ns |
| MET-min/week | 5805 (3689) | 3408 (2895) | 0.002 | 4529 (2973) | 4111 (2903) | ns |
| GI-VAS | ||||||
|
0 | 1 (5) | ns | 0 | 0 | |
|
0 | 1 (5) | ns | 1 (5) | 2 (10) | |
|
25.14 (4.83) | 17.04 (4.67) | 20.35 (5.09) | 22.76 (5.52) | ns | |
|
11.54 (2.93) | 8.56 (2.91) | 9.35 (2.88) | 9.75 (2.94) | ns | |
| Bristol Stool Chart | 3.33 (1.34) | 3.88 (1.51) | ns | 3.32 (1.56) | 3.50 (1.24) | ns |
Values are the mean score ± S.E.M or frequency (%). Physical activity, expressed in MET-minutes per week, decreased significantly for placebo (p = 0.002). BMI: Body Mass Index; MET: metabolic equivalent; GI-VAS: Gastrointestinal Visual Analogue Scale. Ns = not significant.